42 related articles for article (PubMed ID: 32344195)
21. Identification of excimer delayed fluorescence by Protoporphyrin IX: A novel access to local chromophore concentration?
Croizat G; Gregor A; Joniova J; Gerelli E; Wagnières G
J Photochem Photobiol B; 2022 Apr; 229():112408. PubMed ID: 35294918
[TBL] [Abstract][Full Text] [Related]
22. Penetration enhancement of two topical 5-aminolaevulinic acid formulations for photodynamic therapy by erbium:YAG laser ablation of the stratum corneum: continuous versus fractional ablation.
Forster B; Klein A; Szeimies RM; Maisch T
Exp Dermatol; 2010 Sep; 19(9):806-12. PubMed ID: 20636354
[TBL] [Abstract][Full Text] [Related]
23. Light Fractionation Significantly Increases the Efficacy of Photodynamic Therapy Using BF-200 ALA in Normal Mouse Skin.
de Bruijn HS; Brooks S; van der Ploeg-van den Heuvel A; Ten Hagen TL; de Haas ER; Robinson DJ
PLoS One; 2016; 11(2):e0148850. PubMed ID: 26872051
[TBL] [Abstract][Full Text] [Related]
24. The monitoring of the accumulation of protoporphyrin IX in Walker tumours by subcutaneous administration of delta-aminolevulinic acid.
Calin MA; Gruia Ml; Herascu N; Coman T
J Exp Ther Oncol; 2004 Oct; 4(3):247-51. PubMed ID: 15724844
[TBL] [Abstract][Full Text] [Related]
25. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
Orenstein A; Kostenich G; Roitman L; Shechtman Y; Kopolovic Y; Ehrenberg B; Malik Z
Br J Cancer; 1996 Apr; 73(8):937-44. PubMed ID: 8611429
[TBL] [Abstract][Full Text] [Related]
26. Reactive Oxygen Species Produced by 5-Aminolevulinic Acid Photodynamic Therapy in the Treatment of Cancer.
Pignatelli P; Umme S; D'Antonio DL; Piattelli A; Curia MC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240309
[TBL] [Abstract][Full Text] [Related]
27. Special article: measuring mitochondrial oxygen tension: from basic principles to application in humans.
Mik EG
Anesth Analg; 2013 Oct; 117(4):834-846. PubMed ID: 23592604
[TBL] [Abstract][Full Text] [Related]
28. Is interstitial photodynamic therapy for brain tumors ready for clinical practice? A systematic review.
Leroy HA; Guérin L; Lecomte F; Baert G; Vignion AS; Mordon S; Reyns N
Photodiagnosis Photodyn Ther; 2021 Dec; 36():102492. PubMed ID: 34419674
[TBL] [Abstract][Full Text] [Related]
29. The Role of Porphyrinoid Photosensitizers for Skin Wound Healing.
Vallejo MCS; Moura NMM; Gomes ATPC; Joaquinito ASM; Faustino MAF; Almeida A; Gonçalves I; Serra VV; Neves MGPMS
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33923523
[TBL] [Abstract][Full Text] [Related]
30. Imaging of hypoxia, oxygen consumption and recovery in vivo during ALA-photodynamic therapy using delayed fluorescence of Protoporphyrin IX.
Scholz M; Petusseau AF; Gunn JR; Shane Chapman M; Pogue BW
Photodiagnosis Photodyn Ther; 2020 Jun; 30():101790. PubMed ID: 32344195
[TBL] [Abstract][Full Text] [Related]
31. The advantages of aminolevulinic acid photodynamic therapy in dermatology.
Taylor EL; Brown SB
J Dermatolog Treat; 2002; 13 Suppl 1():S3-11. PubMed ID: 12060511
[TBL] [Abstract][Full Text] [Related]
32. 5-Aminolevulinic Acid-Induced Protoporphyrin IX Fluorescence Imaging for Tumor Detection: Recent Advances and Challenges.
Harada Y; Murayama Y; Takamatsu T; Otsuji E; Tanaka H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742921
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
